Later investigations on antiretroviral therapy (ART) have revealed that low CD4/CD8 ratios are also associated with underlying inflammation, oxidative stress, decreased thymic production, and poor control of latent viruses such as CMV, Epstein–Barr virus (EBV), or active coinfections such as hepatitis C (9). This evidence concerns the gene CD8A and Hepatitis.